Evidence map›Paper›PMID 35818721›Full record

ArticleInfluenza and other respiratory viruses2022

Ascertainment of vaccination status by self-report versus source documentation: Impact on measuring COVID-19 vaccine effectiveness.

Meagan Stephenson, Samantha M Olson, Wesley H Self, Adit A Ginde, Nicholas M Mohr, Manjusha Gaglani, Nathan I Shapiro, Kevin W Gibbs, David N Hager, Matthew E Prekker and 21 more

Abstract read
In one paragraph

Article in Influenza and other respiratory viruses, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Observational
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors.

Meagan StephensonCDC COVID-19 Response Team, Atlanta, Georgia, USA.
Samantha M OlsonCDC COVID-19 Response Team, Atlanta, Georgia, USA.ORCID 0000-0003-0589-5766
Wesley H SelfVanderbilt University Medical Center, Nashville, Tennessee, USA.
Adit A GindeUniversity of Colorado School of Medicine, Aurora, Colorado, USA.
Nicholas M MohrUniversity of Iowa, Iowa City, Iowa, USA.
Manjusha GaglaniBaylor Scott & White Health, Temple, Texas, USA.
Nathan I ShapiroBeth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Kevin W GibbsWake Forest University Baptist Medical Center, Winston-Salem, North Carolina, USA.
David N HagerJohns Hopkins Hospital, Baltimore, Maryland, USA.
Matthew E PrekkerHennepin County Medical Center, Minneapolis, Minnesota, USA.
Michelle N GongMontefiore Healthcare Center, Albert Einstein College of Medicine, Bronx, New York, USA.
Jay S SteingrubBaystate Medical Center, Springfield, Massachusetts, USA.
Ithan D PeltanIntermountain Medical Center and University of Utah, Salt Lake City, Utah, USA.
Emily T MartinUniversity of Michigan School of Public Health, Ann Arbor, Michigan, USA.
Raju ReddyOregon Health & Science University Hospital, Portland, Oregon, USA.
Laurence W BusseEmory University School of Medicine, Atlanta, Georgia, USA.
Abhijit DuggalCleveland Clinic, Cleveland, Ohio, USA.
Jennifer G WilsonStanford University School of Medicine, Palo Alto, California, USA.
Nida QadirRonald Reagan-UCLA Medical Center, Los Angeles, California, USA.
Christopher MallowUniversity of Miami, Miami, Florida, USA.
Jennie H KwonWashington University, St. Louis, Missouri, USA.
Matthew C ExlineOhio State University Wexner Medical Center, Columbus, Ohio, USA.
James D ChappellVanderbilt University Medical Center, Nashville, Tennessee, USA.
Adam S LauringUniversity of Michigan School of Medicine, Ann Arbor, Michigan, USA.
Adrienne BaughmanVanderbilt University Medical Center, Nashville, Tennessee, USA.
Christopher J LindsellVanderbilt University Medical Center, Nashville, Tennessee, USA.
Kimberly W HartVanderbilt University Medical Center, Nashville, Tennessee, USA.
Nathaniel M LewisCDC COVID-19 Response Team, Atlanta, Georgia, USA.
Manish M PatelCDC COVID-19 Response Team, Atlanta, Georgia, USA.
Mark W TenfordeCDC COVID-19 Response Team, Atlanta, Georgia, USA.
IVY Network Investigators

Funding

Vanderbilt Institute for Clinical and Translational Research (VICTR) -Identifying correlates of functional immunity in SARS-CoV-2 convalescent plasmaUL1TR002243 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Paul A. Harris, Wesley H Self · 2017 to 2026
$130.7M
Prehospital Activation of ED Teams to Improve Sepsis CareK23GM129661 · NIGMS · IHC HEALTH SERVICES, INC. · PI PELTAN, ITHAN DANIEL · 2019 to 2023
$786k
Longitudinal Analysis of the Fecal Microbiome and Resistome of Patients with Multidrug-Resistant Urinary Tract Infections and Predictors of RecurrenceK23AI137321 · NIAID · WASHINGTON UNIVERSITY · PI KWON, JENNIE H · 2019 to 2022
$675k
CDC HHS 75D30121F00002NCATS NIH HHS UL1 TR002243NIAID NIH HHS K23 AI137321NIGMS NIH HHS K23 GM129661
6 · The paper itself

Abstract

backgroundDuring the COVID-19 pandemic, self-reported COVID-19 vaccination might facilitate rapid evaluations of vaccine effectiveness (VE) when source documentation (e.g., immunization information systems [IIS]) is not readily available. We evaluated the concordance of COVID-19 vaccination status ascertained by self-report versus source documentation and its impact on VE estimates.

methodsHospitalized adults (≥18 years) admitted to 18 U.S. medical centers March-June 2021 were enrolled, including COVID-19 cases and SARS-CoV-2 negative controls. Patients were interviewed about COVID-19 vaccination. Abstractors simultaneously searched IIS, medical records, and other sources for vaccination information. To compare vaccination status by self-report and documentation, we estimated percent agreement and unweighted kappa with 95% confidence intervals (CIs). We then calculated VE in preventing COVID-19 hospitalization of full vaccination (2 doses of mRNA product ≥14 days prior to illness onset) independently using data from self-report or source documentation.

resultsOf 2520 patients, 594 (24%) did not have self-reported vaccination information to assign vaccination group; these patients tended to be more severely ill. Among 1924 patients with both self-report and source documentation information, 95.0% (95% CI: 93.9-95.9%) agreement was observed, with a kappa of 0.9127 (95% CI: 0.9109-0.9145). VE was 86% (95% CI: 81-90%) by self-report data only and 85% (95% CI: 81-89%) by source documentation data only.

conclusionsApproximately one-quarter of hospitalized patients could not provide self-report COVID-19 vaccination status. Among patients with self-report information, there was high concordance with source documented status. Self-report may be a reasonable source of COVID-19 vaccination information for timely VE assessment for public health action.

Indexed as

COVID-19COVID-19 VaccinesAdultDocumentationHumansPandemicsRNA, MessengerSARS-CoV-2Self ReportVaccinationVaccine EfficacyCOVID-19 VaccinesRNA, MessengerconcordanceCOVID-19registryself-reportvaccine effectiveness

Identifiers

PMID35818721
PMCPMC9350035

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.